Mai Aly

659 total citations
26 papers, 280 citations indexed

About

Mai Aly is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Mai Aly has authored 26 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 13 papers in Genetics and 8 papers in Immunology. Recurrent topics in Mai Aly's work include Acute Myeloid Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Mai Aly is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Mai Aly collaborates with scholars based in Egypt, United States and Italy. Mai Aly's co-authors include Gellan K. Ahmed, Jaroslaw P. Maciejewski, Eman M. Khedr, Valeria Visconte, Suresh Kumar Balasubramanian, Bartlomiej Przychodzen, Tomas Radivoyevitch, Swapna Thota, Cassandra M. Hirsch and Shimaa A. Ahmed and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Psychiatry Research.

In The Last Decade

Mai Aly

20 papers receiving 278 citations

Peers

Countries citing papers authored by Mai Aly

Since Specialization

Citations

This map shows the geographic impact of Mai Aly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mai Aly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mai Aly more than expected).

Fields of papers citing papers by Mai Aly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mai Aly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mai Aly. The network helps show where Mai Aly may publish in the future.

Co-authorship network of co-authors of Mai Aly

This figure shows the co-authorship network connecting the top 25 collaborators of Mai Aly. A scholar is included among the top collaborators of Mai Aly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mai Aly. Mai Aly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comprehensive Age-Stratified Impact of NPM1 Mutation in Acute Myeloid Leukemia: A Real-World Experience 2025 ·Cancers ·(unknown), (unknown), (unknown), (unknown), Mai Aly, Tariq Kewan, Waled Bahaj, Carmelo Gurnari, Valeria Visconte, David Carr, Julie L. Boerner, Jay Yang, Gregory Dyson, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian	2
2	Platelet indices as a predictor in patients with aplastic anemia and immune thrombocytopenic purpura: a retrospective case–control study 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Mai Aly	0
3	Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes 2023 ·Blood ·Tariq Kewan, Waled Bahaj, Arda Durmaz, Mai Aly, (unknown), Hetty E. Carraway, Mikkael A. Sekeres, Valeria Visconte, Carmelo Gurnari, Jaroslaw P. Maciejewski	18
4	Renal arterial resistive index as a prognostic marker in lupus nephritis patients 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Mai Aly	0
5	Efficacy analysis of different FLT3 inhibitors in patients with relapsed/refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome 2022 ·SHILAP Revista de lepidopterología ·Mahesh Swaminathan, Mai Aly, (unknown), (unknown), (unknown), (unknown), (unknown), Katherine G. Akers, Seongho Kim, Suresh Kumar Balasubramanian	3
6	Molecular and Clinical PHF6 Mutant Myeloid Neoplasia Provides Clues As to Their Pathogenesis and Therapeutic Targeting 2022 ·Blood ·Yasuo Kubota, (unknown), Carmelo Gurnari, Juraj Bodo, Naomi Kawashima, Mai Aly, Arda Durmaz, Minako Mori, Ben Ponvilawan, Tariq Kewan, Waled Bahaj, Valeria Visconte, Heesun J. Rogers, Torsten Haferlach, Jaroslaw P. Maciejewski	0
7	A Clinically Practicable Approach to Predict TP53 Allelic Configurations in Myeloid Neoplasia 2022 ·Blood ·Waled Bahaj, Tariq Kewan, Carmelo Gurnari, Arda Durmaz, Ben Ponvilawan, (unknown), Yasuo Kubota, (unknown), Mai Aly, Yazan F. Madanat, (unknown), Suresh Kumar Balasubramanian, Minako Mori, Manja Meggendorfer, Hetty E. Carraway, Sudipto Mukherjee, Mikkael A. Sekeres, Torsten Haferlach, Valeria Visconte, Jaroslaw P. Maciejewski	1
8	Molecular and Clinical Spectra of Protein Phosphatase, Mg2+/Mn2+-Dependent 1D (PPM1D)-Mutant Myeloid Neoplasms 2022 ·Blood ·Mai Aly, Valeria Visconte, Carmelo Gurnari, (unknown), Arda Durmaz, Suresh Kumar Balasubramanian, Abhay Singh, Bhumika J. Patel, Tariq Kewan, Waled Bahaj, Jaroslaw P. Maciejewski	1
9	Late Presentation of Dyskeratosis Congenita: Germline Predisposition to Adult-Onset Secondary Acute Myeloid Leukemia 2022 ·SHILAP Revista de lepidopterología ·(unknown), Mai Aly, Suresh Kumar Balasubramanian	0
10	Comprehensive Age-Stratified Impact of NPM1 Mutation in Acute Myeloid Leukemia 2022 ·Blood ·(unknown), (unknown), Mai Aly, (unknown), (unknown), Tariq Kewan, Waled Bahaj, Carmelo Gurnari, (unknown), Gregory Dyson, Valeria Visconte, Suresh Kumar Balasubramanian	1
11	Clinico-Molecular Risk Factors and Management of Thrombosis in a Large Real-Life Cohort of Patients with Paroxysmal Nocturnal Hemoglobinuria in the New Era of Anti-Complement Inhibitors and Doacs 2022 ·Blood ·Carmelo Gurnari, Hussein Awada, Mai Aly, Danai Dima, Fauzia Ullah, Naomi Kawashima, Yasuo Kubota, (unknown), Valeria Visconte, Simona Pagliuca, Bhumika J. Patel, (unknown), Jaroslaw P. Maciejewski	0
12	Revisiting Autoimmunity in Chronic Lymphocytic Leukemia: Prognostic Value of Positive Direct Antiglobulin Test in a Retrospective Study and Literature Review 2021 ·Journal of Blood Medicine ·Shimaa A. Ahmed, (unknown), Mai Aly, (unknown), (unknown)	2
13	Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study 2021 ·Journal of Blood Medicine ·Mai Aly, (unknown), (unknown), Shimaa A. Ahmed, (unknown), (unknown), (unknown)	23
14	CXCR4 as a prognostic marker in Egyptian chronic lymphocytic leukemia patients 2021 ·PubMed ·(unknown), (unknown), Mai Aly, (unknown), (unknown)	4
15	Combined Blood Indexes of Systemic Inflammation as a Mirror to Admission to Intensive Care Unit in COVID-19 Patients: A Multicentric Study 2021 ·Journal of Epidemiology and Global Health ·(unknown), Mai Aly, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	64
16	Long term impact of Covid-19 infection on sleep and mental health: A cross-sectional study 2021 ·Psychiatry Research ·Gellan K. Ahmed, Eman M. Khedr, (unknown), (unknown), (unknown), Mai Aly	65
17	A Systematic Review and Meta-Analysis Comparing Type I and II FLT3 Inhibitors in Relapsed/ Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome 2021 ·Blood ·Mai Aly, Mahesh Swaminathan, Katherine G. Akers, Seongho Kim, (unknown), Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian	1
18	Distinct clinical and biological implications of CUX1 in myeloid neoplasms 2019 ·Blood Advances ·Mai Aly, Zubaidah M. Ramdzan, Yasunobu Nagata, Suresh Kumar Balasubramanian, Naoko Hosono, Hideki Makishima, Valeria Visconte, Teodora Kuzmanovic, Vera Ademà, Aziz Nazha, Bartlomiej Przychodzen, Cassandra M Kerr, Mikkael A. Sekeres, Mohamed E. Abazeed, Alain Nepveu, Jaroslaw P. Maciejewski	26
19	Rational management approach to pure red cell aplasia 2017 ·Haematologica ·Suresh Kumar Balasubramanian, (unknown), Swapna Thota, Mai Aly, Bartlomiej Przychodzen, Cassandra M. Hirsch, Valeria Visconte, Tomas Radivoyevitch, Jaroslaw P. Maciejewski	54
20	TP53 Mutations and Outcome in Patients with Myelodysplastic Syndromes (MDS) 2016 ·Blood ·(unknown), Mikkael A. Sekeres, (unknown), Babal K. Jha, Bartlomiej Przychodzen, Mai Aly, Hetty E. Carraway, Anjali S. Advani, Bhumika J. Patel, Michael J. Clemente, Sudipto Mukherjee, Aaron T. Gerds, Jaroslaw P. Maciejewski, Aziz Nazha	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact